When was Monarch Diagnostics founded?

Monarch Diagnostics was founded in 2019.

Where is Monarch Diagnostics located?

Monarch Diagnostics is headquartered in Irvine, United States.

How many employees does Monarch Diagnostics have?

As of Sep 30, 2026, the latest employee count at Monarch Diagnostics is 35.

Where does Monarch Diagnostics rank among its competitors?

Monarch Diagnostics ranks 4th amongst 48 active competitors, of which 6 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was OneroRx, which secured an undisclosed amount in Jan, 2024.

Who are the top competitors of Monarch Diagnostics?

Monarch Diagnostics' top competitors include Orphalan, NIMBLE Diagnostics and Amber Pharmacy. Among them, OneroRx secured the most recent funding round in January, 2024.

Monarch Diagnostics - 2026 Company Profile & Competitors

Monarch Diagnostics' employee count trend

Monarch Diagnostics has 35 employees as of Sep 26. Here is Monarch Diagnostics's employee count trend over the years:

Employee count trend for Monarch Diagnostics

Uncover Monarch Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Monarch Diagnostics include Orphalan, NIMBLE Diagnostics and Amber Pharmacy. Here is the list of Top 10 competitors of Monarch Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Orphalan 2011, Paris (France), Funding Raised	Developer and provider of access to innovative treatments to patients with rare diseases	-	Advent Life Sciences, Kreos Capital & 1 others	41/100
2nd	NIMBLE Diagnostics 2022, Badalona (Spain), Seed	Developer of diagnostic device for the detection of cardiovascular conditions	$1.08M	Ship2B, Grow Venture Partners & 4 others	40/100
3rd	Amber Pharmacy 2008, Singapore (Singapore), Acquired	Provider of customized approach to diagnosing and delivering specialty medications, with a patient-centric focus on convenient access, personalized care, and comprehensive support	-	-	36/100
4th	Monarch Diagnostics 2019, Irvine (United States), Unfunded	Provider of diagnostic testing services	-	-	35/100
5th	Nutrasource 2002, Guelph (Canada), Acquired	Provider of marketing services for healthcare, nutraceutical & pharmaceutical sector	-	Maxim Corporate Partners	35/100
6th	Shine Spect Janesville (United States), Unfunded	Provider of diagnostic radiopharmaceutical products and artificial intelligence solutions	-	-	34/100
7th	Livivos 2018, San Diego (United States), Funding Raised	Provider of point-of-care liver disease diagnostics devices	-	Particular Ventures, HHS	33/100
8th	Droplet 2015, Gurugram (India), Acquired	Provider of home pathology sample collection and diagnostic tests services	$227K	Tata 1mg	33/100
9th	OneroRx 2021, West Des Moines (United States), Seed	Online platform offering telepharmacy services	-	Cyprium	32/100
10th	Catalys Pacific 2019, Cayman Islands, Unfunded	Provider of diagnostic healthcare investment services	-	-	32/100